BioLineRx Ltd.

NASDAQ: BLRX · Real-Time Price · USD
3.75
-0.02 (-0.53%)
At close: Aug 15, 2025, 3:59 PM
3.78
0.80%
After-hours: Aug 15, 2025, 06:01 PM EDT

BioLineRx Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.22M -60.61M -24.95M -27.05M
Depreciation & Amortization
4.07M 1.38M 654K 703K
Stock-Based Compensation
1.14M 2.32M 2.25M 1.5M
Other Working Capital
-18.51M 12.96M 1.24M -540K
Other Non-Cash Items
-18.03M 19.1M -5.43M 39K
Deferred Income Tax
n/a n/a n/a 1.78M
Change in Working Capital
-21.82M 15.2M 1.24M -540K
Operating Cash Flow
-43.87M -22.61M -26.24M -23.57M
Capital Expenditures
-54K -297K -316K -97K
Cash Acquisitions
n/a n/a -4.14K 38.13K
Purchase of Investments
-26.35M -47.59M -44M -78M
Sales Maturities Of Investments
55.78M 49.33M 48.32M 39.87M
Other Investing Acitivies
-1K -181K 4.14K -38.13K
Investing Cash Flow
29.37M 1.44M 4.01M -38.22M
Debt Repayment
4.28M -1.99M 6.07M -3.57M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
22K 2.96M 5K 10.91M
Financial Cash Flow
20.66M 15.06M 20.44M 57.75M
Net Cash Flow
6.18M -6.33M -2.4M -3.84M
Free Cash Flow
-43.93M -22.91M -26.56M -23.67M